Skip to main content

Table 2 Uni- and multivariate analyses

From: Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer

  

Expression

Univariate analysis

Multivariate analysisa

HR (95% CI)

p

HR (95% CI)

p

GAPDH

PFI

low (<0.25), n = 18

1

 

1

 

high (≥0.25), n = 37

2.1 (1.1-4.0)

0.031

2.1 (1.0-4.5)

0.043

OS

low (<0.25), n = 18

1

 

1

 

high (≥0.25), n = 37

2.8 (1.2-6.5)

0.015

2.3 (1.0-5.6)

0.063

PKM2

PFI

low (<0.70), n = 18

1

 

1

 

high (≥0.70), n = 37

1.2 (0.7-2.3)

0.55

1.5 (0.8-2.8)

0.27

OS

low (<0.70), n = 18

1

 

1

 

high (≥0.70), n = 37

1.1 (0.5-2.2)

0.87

1.2 (0.6-2.6)

0.60

ATP5B

PFI

low (<0.31), n = 18

1

 

1

 

high (≥0.31), n = 37

1.7 (0.9-3.3)

0.089

1.8 (0.9-3.6)

0.097

OS

low (<0.31), n = 18

1

 

1

 

high (≥0.31), n = 37

2.6 (1.1-5.9)

0.025

2.3 (1.0-5.3)

0.062

BEC-index

PFI

low (≤2.65), n = 36

1

 

1

 

high (>2.65), n = 19

0.46 (0.23-0.92)

0.028

0.47 (0.23-0.95)

0.035

OS

low (≤2.65), n = 36

1

 

1

 

high (>2.65), n = 19

0.42 (0.20-0.94)

0.033

0.49 (0.22-1.31)

0.088

  1. Abbreviations: HR, hazard ratio, CI, confidence interval.
  2. aMultivariate model with adjustment for age, FIGO stage, grade and postoperative residual tumor size.
  3. Platinum-free interval (PFI) and overall survival (OS) in relation to mRNA expression of GAPDH, PKM2, ATP5B and BEC-index.